Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,123,051
-
Share change
-
-1,027,170
-
Total reported value
-
$69,164,000
-
Price per share
-
$9.71
-
Number of holders
-
19
-
Value change
-
-$2,050,469
-
Number of buys
-
12
-
Number of sells
-
6
Institutional Holders of ALPINE IMMUNE SCIENCES INC - COM (ALPN) as of Q2 2020
As of 30 Jun 2020,
ALPINE IMMUNE SCIENCES INC - COM (ALPN) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,123,051 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FRAZIER MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, TIGER MANAGEMENT L.L.C., TWO SIGMA INVESTMENTS, LP, Berman Capital Advisors, LLC, Hikari Power Ltd, DIMENSIONAL FUND ADVISORS LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.